Geneos Wealth Management’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.4K Buy
48
+26
+118% +$11.9K ﹤0.01% 2092
2026
Q2
$12.4K Buy
22
+2
+10% +$1.29K ﹤0.01% 1947
2026
Q1
$10.4K Buy
20
+7
+54% +$3.56K ﹤0.01% 1977
2025
Q4
$5.92K Buy
+13
New +$5.66K ﹤0.01% 2104
2025
Q3
– Sell
-66
Closed -$19.4K – 2739
2025
Q2
$19.4K Buy
66
+25
+61% +$5.57K ﹤0.01% 2040
2025
Q1
$8.1K Buy
41
+29
+242% +$6.33K ﹤0.01% 2344
2024
Q4
$2.64K Hold
12
– – ﹤0.01% 2522
2024
Q3
$2.84K Sell
12
-75
-86% -$17.4K ﹤0.01% 2213
2024
Q2
$21.3K Hold
87
– – ﹤0.01% 1327
2024
Q1
$16.4K Buy
+87
New +$17.5K ﹤0.01% 1424
2022
Q2
– Sell
-24
Closed -$2K – 2654
2022
Q1
$2K Buy
+24
New +$2.54K ﹤0.01% 2542
2018
Q1
– Sell
-46
Closed -$1K – 2194
2017
Q4
$1K Hold
46
– – ﹤0.01% 2093
2017
Q3
$1K Hold
46
– – ﹤0.01% 2040
2017
Q2
$1K Hold
46
– – ﹤0.01% 1991
2017
Q1
$1K Hold
46
– – ﹤0.01% 1979
2016
Q4
$1K Hold
46
– – ﹤0.01% 1951
2016
Q3
$2K Buy
+46
New +$1.83K ﹤0.01% 1773

Other funds holding FN

Geneos Wealth Management's FN Position: Q3 2026 in Review

Geneos Wealth Management increased its Fabrinet (FN) stake by 118% in Q3 2026, buying an estimated $11.9K and bringing the position to 48 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Geneos Wealth Management first reported a position in FN in Q3 2016 and has held it in 17 quarters since. The position peaked at $21.3K in Q2 2024. 685 funds tracked by Wall St. Rank hold FN as of Q3 2026.

  • Geneos Wealth Management held 48 shares of Fabrinet worth $20.4K as of Q3 2026.
  • Geneos Wealth Management bought 26 Fabrinet shares in Q3 2026, an estimated $11.9K.
  • Fabrinet made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2092 holding.
  • Geneos Wealth Management first reported a position in Fabrinet in Q3 2016 and has held it in 17 quarters since.
  • Geneos Wealth Management's Fabrinet position peaked at $21.3K in Q2 2024.
  • 685 funds tracked by Wall St. Rank held Fabrinet as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.